SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Short Term Loans and Advances History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Short Term Loans and Advances | ₹30 Cr | ₹20 Cr | ₹9.63 Cr | ₹8.23 Cr | ₹18 Cr |
What is the latest Short Term Loans and Advances ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Short Term Loans and Advances |
|---|---|
| Mar2025 | ₹30 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹9.63 Cr |
| Mar2022 | ₹8.23 Cr |
| Mar2017 | ₹18 Cr |
How is Short Term Loans and Advances of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Short Term Loans and Advances | % Change | |
|---|---|---|---|
| Mar2025 | ₹30 Cr | 53.89 | |
| Mar2024 | ₹20 Cr | 103.46 | |
| Mar2023 | ₹9.63 Cr | 16.97 | |
| Mar2022 | ₹8.23 Cr | -53.05 | |
| Mar2017 | ₹18 Cr | - | |
Compare Short Term Loans and Advances of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,412.8 Cr | 4.9% | 7.7% | -19.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,096.0 Cr | -2.4% | 3% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,807.0 Cr | -3.3% | 3.5% | 4.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,718.0 Cr | -2% | 5% | 43.1% | Stock Analytics | |
| CIPLA | ₹112,971.0 Cr | -0% | 6.9% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,752.0 Cr | -0.3% | -3.8% | 7.3% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | 4.9% |
7.7% |
-19.8% |
| SENSEX | -0.5% |
-3.3% |
-7.6% |
You may also like the below Video Courses